Efficacy of Gabapentin for Post-Covid-19 Olfactory Dysfunction
Status:
Not yet recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
This study will investigate the efficacy of oral gabapentin in olfactory improvement
following Covid-19- associated olfactory dysfunction. This is a randomized, double-blinded,
placebo-controlled trial.